このエントリーをはてなブックマークに追加
ID 69952
フルテキストURL
著者
Harada, Ko Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai
Nishimura, Yoshito Division of Hematology/Oncology, Mayo Clinic
Vu, Quynh Thi Department of Health Data Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Yamamoto, Maki Department of Health Data Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Koyama, Toshihiro Department of Health Data Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Hagiya, Hideharu Department of Infectious Diseases, Okayama University Hospital ORCID Kaken ID researchmap
抄録
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and ultimately fatal lung disease. Updated global mortality data, especially from underexplored countries, are limited. This study aimed to understand the current global trends in IPF-associated mortality rates.
Methods This observational study used the World Health Organization Mortality Database to analyse data stratified by sex, age and geographic region, encompassing 64 countries between 2001 and 2022. IPF was defined according to the International Code for Diseases-10 code J84.1. Crude and age-standardised mortality rates per 100 000 individuals were calculated to estimate long-term mortality trends. Mortality rates were calculated by dividing IPF-associated deaths by the corresponding population, with age-specific rates determined for each 5-year age group. Trends in the 2001–2022 period were analysed using a locally weighted regression model, and the average annual percentage change in mortality rates between 2010 and 2022 was estimated using joinpoint regression analysis.
Results Overall, 874 998 deaths associated with IPF were analysed. The LOESS-smoothed crude mortality rate increased from 2.10 (95% confidence interval (CI) 1.77–2.43) per 100 000 in 2001 to 3.14 (95% CI 2.71–3.57) per 100 000 by 2022. The LOESS-smoothed age-standardised mortality rates increased overall, peaking at 1.59 (95% CI 1.51–1.67) per 100 000 in 2018 and declining slightly to 1.57 (95% CI 1.35–1.79) per 100 000 in 2022. Mortality was higher among males than females; furthermore, 87.5% of deaths occurred in individuals aged ≥65 years. Mortality rates were highest among the American population, with a notable increase in Latin American countries.
Conclusion IPF-associated mortality rates have increased globally, particularly in males. Significant geographical, age and sex disparities were observed, emphasising the need for targeted public health measures and improved disease management.
発行日
2025-06-03
出版物タイトル
ERJ Open Research
11巻
6号
出版者
European Respiratory Society (ERS)
開始ページ
00362-2025
ISSN
2312-0541
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
©The authors 2025
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1183/23120541.00362-2025
ライセンス
http://creativecommons.org/licenses/by-nc/4.0/
Citation
Harada K, Nishimura Y, Vu QT, et al. Global trends in idiopathic pulmonary fibrosis mortality rates during 2001–2022. ERJ Open Res 2025; 11: 00362-2025 [DOI: 10.1183/23120541.00362-2025].
助成情報
22K10415: 医療データサイエンスによる高齢者医療の疾病構造に関する臨床疫学研究 ( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )